Block

Meet the expert webinar

Developing Your Commercial Strategy in Phases II-III

As market access challenges intensify, pharma companies are beginning their commercialization planning much earlier in the product lifecycle. Advance market research helps manufacturers learn which differentiators are necessary for a successful launch—information that ultimately informs the decision to move forward with an asset.

In this webinar, we’ll examine how pharma companies can use data and insights to make the most of this critical stage. We’ll discuss how targeted investments in Phase 2B/3 can provide an early look at access barriers throughout the patient journey. We’ll share how manufacturers can determine which stakeholders matter most, what they need to hear, and how to effectively reach them to secure access. With this foundation, manufacturers can reverse-engineer a successful go-to-market plan.

You will learn:

  • How early identification of payer priorities can inform your Phase III endpoints and result in a stronger value story
  • Why understanding access roadblocks and the patient’s path to diagnosis helps your team allocate resources effectively
  • How segmenting payers by attributes helps your team develop a payer prioritization and contracting strategy for sales

Access the Webinar


Team #4
webinar-author-sean-wagner

Sean Wagner

VP, Client Partnership | MMIT

Sean Wagner is vice president of Client Partnership at MMIT, where he leverages his background in pharmaceutical information, analytics, and marketing communication to lead client teams. Sean has more than 30 years of industry experience in strategic consulting, account management, and BU leadership, most recently in market access at MediMedia/ICON plc. He holds a Master of Public Health degree from the University of Michigan.

webinar-author-carolyn-zele

Carolyn Zele

Advisor Solution Consulting Team | MMIT

Carolyn Zele is an advisor for MMIT’s solution consulting team who helps pharmaceutical manufacturers simplify market access and prepare for launch success. Prior to MMIT, Carolyn spent numerous years in the payer/PBM space managing formulary teams and technology across both regulated and non-regulated lines of business. She holds a Master of Science degree from Colorado State University.